{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "The iPREDICT Study: A Randomised Controlled Trial on Interactive Consultation Tool for Anaesthesia Risk Education"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised 1:1"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible participants were adults scheduled for elective surgery under general or combined anaesthesia."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised 1:1 to receive either ICT-based online anaesthesia risk education (intervention) or a control video without anaesthetic risk content."
      },
      "Objective": {
        "score": 1,
        "evidence": "The iPREDICT study aimed to evaluate the effectiveness of an interactive consultation tool (ICT) in enhancing patient awareness of anaesthesia-related risks during preoperative anaesthetic assessment (PAA)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the perioperative risk knowledge score, assessed immediately after PAA and two days later."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a cryptographically secure pseudo-random number generator, with allocation concealed within the software."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was not feasible for patients or clinicians."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 373 participants were randomised (186 to ICT, 187 to control)"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis included 275 participants (139 ICT, 136 control) using a per-protocol approach."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The ICT group demonstrated a higher median risk knowledge score post-PAA (13.0 vs. 11.0, p < 0.05) and further improvement at follow-up (14.0 vs. 13.0, p < 0.05)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: DRKS00032514."
      },
      "Funding": {
        "score": 1,
        "evidence": "The study was funded by the University Hospital Bonn."
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}